Formulation and Evaluation of Microspheres of Ramipril
Abstract
Background: Ramipril an antihypertensive medicine has a 28 percent oral bioavailability and is promptly eliminated from the body through the kidneys. When Ramipril is administered as an immediate dosage form, it has also been linked to a wide range of side effects, including hypotension, an increase in potassium level, and angioedema. The present study was therefore conducted in an effort to reduce the drug's negative effects and boost its bioavailability.
Objectives: In the current work, ramipril microspheres are created and evaluated utilizing the solvent evaporation method and natural or synthetic polymers. Use natural polymers like ramipril, sodium hydroxide, potassium dihydrogen orthophosphate, dichloromethane (DCM), and synthetic polymers like ethyl cellulose, eudragit RL100, etc.
Methods: A solvent evaporation technique was used to create the microsphere, and polymers like EudragitRL100 and ethyl cellulose were used. Particle size analysis, percent entrapment efficiency, Differential scanning calorimetry (DSC), Drug encapsulation efficiency (DEE), FTIR spectroscopy, in vitro release research, and stability study were all performed on the produced formulations.
Results: The results were observed to be within the normative ranges. The FT-IR analysis of the formulations indicated there was no interaction between Ramipril and other excipients. The range of entrapment efficiency was found to be between 68.7 and 94.08%. The drug release investigation was conducted in gastrointestinal fluid (SGF) for 12 hours and demonstrated the largest quantity of drug release in a regulated and sustained manner over a prolonged length of time. The size of the microsphere was in the range of 25.7 to 49.2 m. According to the DSC study, molecules of drugs are uniformly dispersed in an amorphous state.
Conclusion: The designed formulation was discovered to be stable and it provides a potential system for the controlled and sustained distribution of ramipril.
Keywords: Ramipril, EudragitRL100, Ethylcellulose, Potassium dihydrogen orthophosphate, Solvent evaporation method.
Keywords:
Ramipril, EudragitRL100, Ethylcellulose, Potassium dihydrogen orthophosphate, Solvent evaporation methodDOI
https://doi.org/10.22270/jddt.v12i4-S.5486References
Delie F, Blanco-Pricto MJ. Polymeric particulates to improve oral bioavailability of peptide drugs. Molecules 2005; 10:65-80. https://doi.org/10.3390/10010065
AHFS; Drug Information American society of health system pharmacists, Inc.7272 Wisconsin Avenue, Bethseda, MD 20814,2004:1869-75
Amit KN, Ruma M, Biswarup D. Gastroretentive drug delivery systems: a review. Asian J Pharm Clin Res. 2010 Jan;3(1):2-10.
Kumari N, Aggarwal G, Harikumar SL. Mucoadhesive microspheres: A review. Journal of Drug Delivery and Therapeutics. 2014 Sep 14; 4(5):48-54. https://doi.org/10.22270/jddt.v4i5.953
Ahmed SI, Zaheer Z, Khan FN, Hasan M. The formulation and evaluation of gastro-bilayer floating tablets of losartan potassium as immediate release layer and ramipril hydrochloride as sustained release floating layer. International Journal of Pharmaceutical Investigation. 2020 Oct 2; 10(3):294-9 https://doi.org/10.5530/ijpi.2020.3.53
Mahale MM, Saudagar RB, Microsphere: a review, Journal of drug delivery and therapeutics 2019; 9(3-s):854-856
Vakhariya RR, Salunkhe VR, Randive DS, Bhutkar MA, Bhinge SD. Design, Development and Optimization of Ramipril Solid Lipid Nanoparticles Using Solvent Emulsification and Evaporation Method. Nanoscience & Nanotechnology-Asia. 2021 Feb 1; 11(1):42-52. https://doi.org/10.2174/2210681209666191204113659
Mutagond C, Vinod MR, Vijapure VM, Marapur SC, Patil RG, Jorapur PN, Biradar PN. Formulation and Evaluation of Spray Dried Microspheres of Controlled Release Ramipril. International Journal of Pharmaceutical Sciences and Nanotechnology. 2018 Mar 31; 11(2):4059-66. https://doi.org/10.37285/ijpsn.2018.11.2.8
Madhavi KA, Shikha A, Yadav JK. Self-Nano emulsifying drug delivery system of ramipril: formulation and in vitro evaluation. Int J Pharm Pharm Sci. 2016 Apr; 8(4):291-6
Nagel N, Schweitzer H, Urbach H, Heyse W, Müller B, Berchtold H. Ramipril. Acta Crystallographica Section E: Structure Reports Online. 2001 May 1;57(5):o463-5.Neeta MM, Satija S, Pandey P, Dahiya M. Relevance of ionotropic gelation technique in the development of floating multiparticulate drug delivery systems. Int J Adv Sci Research. 2016; 1(4):54-9. https://doi.org/10.1107/S1600536801006948
Messerli FH, Bangalore S, Bavishi C, Rimoldi SF. Angiotensin-converting enzyme inhibitors in hypertension: to use or not to use?. Journal of the American College of Cardiology. 2018 Apr 3; 71(13):1474-82. https://doi.org/10.1016/j.jacc.2018.01.058
https://en.wikipedia.org/wiki/Ramipril
Kadam NR, Suvarna V. Microsphere: a brief review. Asian Journal of Biomedical and Pharmaceutical Sciences. 2015 Aug 1; 5(47):13. https://doi.org/10.15272/ajbps.v5i47.713
Midha K, Nagpal M, Arora S. Microspheres: a recent update. Int. J. Recent. Sci. Res., 2015; l(8):5859-67.
Ratnaparkhi MP, Wattamwar MM, Jadhav AN, Chaudhari SP. Mucoadhesive Microsphere-Review. International Journal of Drug Development and Research. 2014; 6(2):0-.
Ekambaram P, Sathali AA. Formulation and evaluation of solid lipid nanoparticles of ramipril. Journal of young pharmacists. 2011 Jul 1; 3(3):216-20. https://doi.org/10.4103/0975-1483.83765
Shafiq S, Shakeel F, Talegaonkar S, Ahmad FJ, Khar RK, Ali M. Design and development of oral oil in water ramipril nanoemulsion formulation: in vitro and in vivo assessment. Journal of Biomedical Nanotechnology. 2007 Apr 1; 3(1):28-44 https://doi.org/10.1166/jbn.2007.008
Saini D, Asija R. Formulation development and evaluation of floating drug delivery of gelucire beads of ramipril. Int J Pharm Erud. 2019 Nov; 9(3):21-31.
Ahmed M, Ahamed SK, Dewan SM, Moghal MM. Development of sustained release matrix tablets of ramipril and evaluation of polymer effect on in-vitro release pattern. International Journal of Pharmaceutical Sciences and Research. 2013 Mar 1; 4(3):1039.
Chadha R, Bhandari S, Kataria D, Gupta S. Exploring lecithin/chitosan nanoparticles of ramipril for improved antihypertensive efficacy. Journal of Nanopharmaceutics and Drug Delivery. 2013 Jun 1; 1(2):173-81. https://doi.org/10.1166/jnd.2013.1014
Published
Abstract Display: 1376 
PDF Downloads: 764 PDF Downloads: 193 How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.